Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step

Publication date

2010

Authors

Widjaja, IvyISNI 0000000069230358
Vries, Erik deISNI 0000000393812384
Tscherne, D.M.
García-Sastre, A.
Rottier, PeterISNI 0000000029654607
de Haan, Cornelis A MORCID 0000-0002-4459-9874ISNI 0000000395765470

Editors

Advisors

Supervisors

Document Type

Article

License

Abstract

We have demonstrated that influenza A virus (IAV) RNA synthesis depends on the ubiquitin-proteasome system. IAV replication was reduced both by proteasome inhibitors and in E36ts20 cells, which contain the thermolabile ubiquitin-activating enzyme E1. While virus entry was not affected in E36ts20 cells, the proteasome inhibitor MG132 retained viral particles in the cytoplasm. Addition-removal experiments of MG132 in combination with bafilomycin A1, a well-established inhibitor of IAV entry and fusion, showed that MG132 affected IAV infection at a postfusion step. This was confirmed by the lack of inhibition of IAV entry by proteasome inhibitors in a virus-like particle fusion assay.

Keywords

Citation

Widjaja, I, de Vries, E, Tscherne, D M, García-Sastre, A, Rottier, P J M & de Haan, C A M 2010, 'Inhibition of the ubiquitin-proteasome system affects influenza A virus infection at a postfusion step', Journal of Virology, vol. 84, no. 18, pp. 9625-9631. https://doi.org/10.1128/jvi.01048-10